Candidiasis. Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
Conditions
Interventions
Intervention 1: Women in the intervention group will be used clotrimazol vaginal cream1% for internal use and Deo drug pan jell for external use. Duration of intervention will be 2 weeks. The clotrima
Treatment - Drugs
Women in the intervention group will be used clotrimazol vaginal cream1% for internal use and Deo drug pan jell for external use. Duration of intervention will be 2 weeks. The clotrimazol vaginal crea
Women in the controlled group will be used clotrimazol vaginal cream1% as well as intervention group and for external use, they use clotrimazol topical cream. Duration of intervention will be 2 weeks.
Sponsors
Nictin drug industry
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria of this study is marital statues, confirmed clinical diagnosis of candida vulvovaginitis, chief compliant of external symptoms and signs of vulvovaginitis, no usage of herbal medicine or any chemical antibiotics especially in the recent two weeks, no history of AUB, no usage of vaginal douching in the past 48 hours. Exclusion criteria of this study are overt diabet melitus, Immunosuppressive diseases,Vaginal drugs usage (as creams or gels) during the 4 weeks prior to study pregnancy, menopause, cervicitis, positive history of candidiasis more than 3 times per recent year, abnormal pap smear per recent year,having more than one sexual partner, and PID.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical signs of candidia vaginitis. Timepoint: before and afert the intervention. Method of measurement: clinical pelvic exam observationform.;Clinical symptoms experienced by the patient. Timepoint: from the begining of the intervention untill finished it. Method of measurement: dailty patenit cheklist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence of the vaginitis. Timepoint: 4 weeks after the treatment. Method of measurement: recurrence evaluation form.;Level of drug use satisfaction. Timepoint: after the intervention. Method of measurement: drug use satisfaction form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Raziyeh Maasoumi
Tehran University of Medical Sciences
Outcome results
None listed